237 related articles for article (PubMed ID: 23526299)
1. Ligand-independent activation of MET through IGF-1/IGF-1R signaling.
Varkaris A; Gaur S; Parikh NU; Song JH; Dayyani F; Jin JK; Logothetis CJ; Gallick GE
Int J Cancer; 2013 Oct; 133(7):1536-46. PubMed ID: 23526299
[TBL] [Abstract][Full Text] [Related]
2. Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways.
Dayyani F; Parikh NU; Varkaris AS; Song JH; Moorthy S; Chatterji T; Maity SN; Wolfe AR; Carboni JM; Gottardis MM; Logothetis CJ; Gallick GE
PLoS One; 2012; 7(12):e51189. PubMed ID: 23300537
[TBL] [Abstract][Full Text] [Related]
3. Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer.
Min HY; Yun HJ; Lee JS; Lee HJ; Cho J; Jang HJ; Park SH; Liu D; Oh SH; Lee JJ; Wistuba II; Lee HY
Mol Cancer; 2015 Jun; 14():113. PubMed ID: 26041671
[TBL] [Abstract][Full Text] [Related]
4. The interaction of protein-tyrosine phosphatase α (PTPα) and RACK1 protein enables insulin-like growth factor 1 (IGF-1)-stimulated Abl-dependent and -independent tyrosine phosphorylation of PTPα.
Khanna RS; Le HT; Wang J; Fung TC; Pallen CJ
J Biol Chem; 2015 Apr; 290(15):9886-95. PubMed ID: 25694432
[TBL] [Abstract][Full Text] [Related]
5. Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes.
Zhang Y; Moerkens M; Ramaiahgari S; de Bont H; Price L; Meerman J; van de Water B
Breast Cancer Res; 2011 May; 13(3):R52. PubMed ID: 21595894
[TBL] [Abstract][Full Text] [Related]
6. c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential.
Wu X; Zhou J; Rogers AM; Jänne PA; Benedettini E; Loda M; Hodi FS
Melanoma Res; 2012 Apr; 22(2):123-32. PubMed ID: 22343486
[TBL] [Abstract][Full Text] [Related]
7. Protein tyrosine phosphatase-alpha complexes with the IGF-I receptor and undergoes IGF-I-stimulated tyrosine phosphorylation that mediates cell migration.
Chen SC; Khanna RS; Bessette DC; Samayawardhena LA; Pallen CJ
Am J Physiol Cell Physiol; 2009 Jul; 297(1):C133-9. PubMed ID: 19420001
[TBL] [Abstract][Full Text] [Related]
8. Combating resistance to anti-IGFR antibody by targeting the integrin β3-Src pathway.
Shin DH; Lee HJ; Min HY; Choi SP; Lee MS; Lee JW; Johnson FM; Mehta K; Lippman SM; Glisson BS; Lee HY
J Natl Cancer Inst; 2013 Oct; 105(20):1558-70. PubMed ID: 24092920
[TBL] [Abstract][Full Text] [Related]
9. Fyn is downstream of the HGF/MET signaling axis and affects cellular shape and tropism in PC3 cells.
Jensen AR; David SY; Liao C; Dai J; Keller ET; Al-Ahmadie H; Dakin-Haché K; Usatyuk P; Sievert MF; Paner GP; Yala S; Cervantes GM; Natarajan V; Salgia R; Posadas EM
Clin Cancer Res; 2011 May; 17(10):3112-22. PubMed ID: 21364031
[TBL] [Abstract][Full Text] [Related]
10. Activation of β1 integrins and caveolin-1 by TF/FVIIa promotes IGF-1R signaling and cell survival.
Åberg M; Edén D; Siegbahn A
Apoptosis; 2020 Aug; 25(7-8):519-534. PubMed ID: 32458278
[TBL] [Abstract][Full Text] [Related]
11. Development of the phenylpyrazolo[3,4-
Lee HJ; Pham PC; Pei H; Lim B; Hyun SY; Baek B; Kim B; Kim Y; Kim MH; Kang NW; Min HY; Kim DD; Lee J; Lee HY
Theranostics; 2021; 11(4):1918-1936. PubMed ID: 33408789
[No Abstract] [Full Text] [Related]
12. Enterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells.
Chen LH; Fang J; Sun Z; Li H; Wu Y; Demark-Wahnefried W; Lin X
J Nutr; 2009 Apr; 139(4):653-9. PubMed ID: 19211828
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of IGF-1 signaling by genistein: modulation of E-cadherin expression and downregulation of β-catenin signaling in hormone refractory PC-3 prostate cancer cells.
Lee J; Ju J; Park S; Hong SJ; Yoon S
Nutr Cancer; 2012; 64(1):153-62. PubMed ID: 22098108
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effects of NKX3.1 on IGF-1R expression and its signalling pathway in human prostatic carcinoma PC3 cells.
Zhang PJ; Hu XY; Liu CY; Chen ZB; Ni NN; Yu Y; Yang LN; Huang ZQ; Liu QW; Jiang AL
Asian J Androl; 2012 May; 14(3):493-8. PubMed ID: 22179513
[TBL] [Abstract][Full Text] [Related]
15. Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells.
Bauer TW; Somcio RJ; Fan F; Liu W; Johnson M; Lesslie DP; Evans DB; Gallick GE; Ellis LM
Mol Cancer Ther; 2006 Jul; 5(7):1676-82. PubMed ID: 16891453
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells.
Yamamoto N; Mammadova G; Song RX; Fukami Y; Sato K
J Cell Sci; 2006 Nov; 119(Pt 22):4623-33. PubMed ID: 17062641
[TBL] [Abstract][Full Text] [Related]
17. HGF-independent potentiation of EGFR action by c-Met.
Dulak AM; Gubish CT; Stabile LP; Henry C; Siegfried JM
Oncogene; 2011 Aug; 30(33):3625-35. PubMed ID: 21423210
[TBL] [Abstract][Full Text] [Related]
18. Thrombin regulates insulin-like growth factor-1 receptor transcription in vascular smooth muscle: characterization of the signaling pathway.
Du J; Brink M; Peng T; Mottironi B; Delafontaine P
Circ Res; 2001 May; 88(10):1044-52. PubMed ID: 11375274
[TBL] [Abstract][Full Text] [Related]
19. Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells.
Li M; Chiu JF; Gagne J; Fukagawa NK
J Cell Physiol; 2008 Nov; 217(2):377-87. PubMed ID: 18615585
[TBL] [Abstract][Full Text] [Related]
20. Novel C6-substituted 1,3,4-oxadiazinones as potential anti-cancer agents.
Alam MM; Lee SC; Jung Y; Yun HJ; Min HY; Lee HJ; Pham PC; Moon J; Kwon DI; Lim B; Suh YG; Lee J; Lee HY
Oncotarget; 2015 Dec; 6(38):40598-610. PubMed ID: 26515601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]